DexCom (DXCM) Misses Q2 EPS by 2c
Tweet
Share
E-mailGet Alerts DXCM Hot Sheet
Price: $89.17 --0%
Revenue Growth %: +9.9%
Financial Fact:
Total operating expenses: 119.6M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +9.9%
Financial Fact:
Total operating expenses: 119.6M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
DexCom (NASDAQ: DXCM) reported Q2 EPS of $0.17, $0.02 worse than the analyst estimate of $0.19. Revenue for the quarter came in at $696.2 million versus the consensus estimate of $700.45 million.
GUIDANCE:
DexCom sees Q3 2022 revenue of $2.86-2.91 billion, versus the consensus of $2.92 billion.
For earnings history and earnings-related data on DexCom (DXCM) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Meta AI agent ‘Muse’ triggers massive tech rally as chips and Wall Street soar
- Thor Industries (THO) Misses Q4 EPS by 13c
- Raymond James Starts Western Alliance Bancorporation (WAL) at Outperform
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
